Skip to main content
. 2013 Nov 26;6:489. doi: 10.1186/1756-0500-6-489

Figure 3.

Figure 3

Positron emission tomography scanning after 8 months of crizotinib treatment: still complete response in the thorax but marked disease progression in the abdomen with newly appeared metastases in retroperitoneal, pelvic and inguinal lymph nodes.